{"id":386174,"date":"2021-04-30T00:00:00","date_gmt":"2021-04-30T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360ha0012-medtech-hyaluronic-acid-viscosupplementation-market-insights-global-2022\/"},"modified":"2026-05-02T11:06:50","modified_gmt":"2026-05-02T11:06:50","slug":"m360ha0012-medtech-hyaluronic-acid-viscosupplementation-market-insights-global-2022","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360ha0012-medtech-hyaluronic-acid-viscosupplementation-market-insights-global-2022\/","title":{"rendered":"Hyaluronic Acid Viscosupplementation | Market Insights | Global | 2022"},"content":{"rendered":"<p>Overall, the\u00a0HA\u00a0viscosupplementation market has seen a substantial negative impact due to the\u00a0COVID-19\u00a0pandemic. Although some procedures have begun to recover, a sizable proportion of\u00a0HA\u00a0viscosupplementation procedures are still being deferred due to\u00a0COVID-19. That said, the market will continue to recover going forward as a larger proportion of the population is vaccinated. Beyond the impact of the pandemic, the global market for\u00a0HA\u00a0viscosupplementation will exhibit modest growth through 2030. While premium-priced 1-injection products will continue to become more popular over the forecast period, 3- and 5-injection products will continue to be preferred in some countries due to differences in product access, cost, and reimbursement.\u00a0<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for the US, Europe, Asia Pacific, and Brazil\u00a0across an 11-year period.<\/p>\n","protected":false},"template":"","class_list":["post-386174","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-date-949"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386174\/revisions"}],"predecessor-version":[{"id":387683,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386174\/revisions\/387683"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}